Daiwa Securities Group Inc. Arcellx, Inc. Transaction History
Daiwa Securities Group Inc.
- $22.4 Billion
- Q4 2024
A detailed history of Daiwa Securities Group Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 178 shares of ACLX stock, worth $11,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178
Previous 204
12.75%
Holding current value
$11,340
Previous $17,000
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
227Shares Held
45MCall Options Held
450KPut Options Held
647K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$279 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$239 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$224 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$222 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$212 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.79B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...